Jennison Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Jennison Associates’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22B	Sell	2,740,059 -509,482	-16%	-$238M	0.84%	29
2025 Q4	$1.47B	Sell	3,249,541 -205,406	-6%	-$88.5M	0.88%	30
2025 Q3	$1.35B	Sell	3,454,947 -2,696,558	-44%	-$1.13B	0.79%	31
2025 Q2	$2.74B	Buy	6,151,505 +1,089,063	+22%	+$502M	1.62%	15
2025 Q1	$2.45B	Buy	5,062,442 +744,680	+17%	+$347M	1.72%	13
2024 Q4	$1.74B	Sell	4,317,762 -1,232,624	-22%	-$571M	1.06%	22
2024 Q3	$2.58B	Buy	5,550,386 +851,054	+18%	+$409M	1.6%	14
2024 Q2	$2.2B	Sell	4,699,332 -83,042	-2%	-$36M	1.41%	18
2024 Q1	$2B	Buy	4,782,374 +837,461	+21%	+$354M	1.34%	18
2023 Q4	$1.61B	Buy	3,944,913 +147,248	+4%	+$54.4M	1.2%	26
2023 Q3	$1.32B	Sell	3,797,665 -7,976	-0.2%	-$2.79M	1.12%	26
2023 Q2	$1.34B	Sell	3,805,641 -774,160	-17%	-$261M	1.1%	26
2023 Q1	$1.44B	Sell	4,579,801 -535,739	-10%	-$161M	1.32%	20
2022 Q4	$1.48B	Buy	5,115,540 +359,719	+8%	+$110M	1.5%	17
2022 Q3	$1.38B	Buy	4,755,821 +2,983,253	+168%	+$858M	1.37%	18
2022 Q2	$499M	Buy	1,772,568 +1,422,478	+406%	+$381M	0.5%	42
2022 Q1	$91.4M	Sell	350,090 -433,299	-55%	-$103M	0.07%	131
2021 Q4	$172M	Sell	783,389 -45,970	-6%	-$8.94M	0.11%	85
2021 Q3	$150M	Buy	829,359 +37,531	+5%	+$7.33M	0.1%	91
2021 Q2	$160M	Buy	791,828 +76,039	+11%	+$15.9M	0.11%	87
2021 Q1	$154M	Sell	715,789 -3,033,565	-81%	-$666M	0.11%	86
2020 Q4	$886M	Buy	3,749,354 +140,270	+4%	+$32.2M	0.63%	41
2020 Q3	$982M	Sell	3,609,084 -809,397	-18%	-$223M	0.79%	39
2020 Q2	$1.28B	Buy	4,418,481 +56,726	+1%	+$15.4M	1.16%	24
2020 Q1	$1.04B	Buy	4,361,755 +790,506	+22%	+$181M	1.26%	22
2019 Q4	$782M	Sell	3,571,249 -2,406,492	-40%	-$487M	0.79%	37
2019 Q3	$1.01B	Sell	5,977,741 -366,718	-6%	-$64.9M	1.07%	29
2019 Q2	$1.16B	Sell	6,344,459 -455,977	-7%	-$79.7M	1.15%	26
2019 Q1	$1.25B	Sell	6,800,436 -141,185	-2%	-$26.1M	1.24%	24
2018 Q4	$1.15B	Buy	6,941,621 +739,128	+12%	+$128M	1.29%	23
2018 Q3	$1.2B	Buy	6,202,493 +1,139,486	+23%	+$203M	1.1%	27
2018 Q2	$861M	Sell	5,063,007 -1,712,321	-25%	-$265M	0.84%	37
2018 Q1	$1.1B	Buy	6,775,328 +1,237,421	+22%	+$202M	1.1%	27
2017 Q4	$830M	Sell	5,537,907 -479,859	-8%	-$71.1M	0.82%	42
2017 Q3	$915M	Buy	6,017,766 +962,644	+19%	+$145M	0.94%	29
2017 Q2	$651M	Buy	5,055,122 +3,626,368	+254%	+$437M	0.69%	40
2017 Q1	$156M	Buy	1,428,754 +125,744	+10%	+$11.1M	0.17%	89
2016 Q4	$96M	Sell	1,303,010 -3,877,751	-75%	-$316M	0.11%	159
2016 Q3	$452M	Buy	5,180,761 +2,205,961	+74%	+$208M	0.49%	49
2016 Q2	$256M	Buy	2,974,800 +1,920,658	+182%	+$166M	0.28%	65
2016 Q1	$83.8M	Sell	1,054,142 -1,029,650	-49%	-$93.1M	0.09%	194
2015 Q4	$262M	Sell	2,083,792 -250,915	-11%	-$30.3M	0.26%	71
2015 Q3	$243M	Sell	2,334,707 -2,770,547	-54%	-$356M	0.25%	78
2015 Q2	$630M	Sell	5,105,254 -1,443,237	-22%	-$182M	0.58%	49
2015 Q1	$773M	Sell	6,548,491 -157,255	-2%	-$18.8M	0.71%	43
2014 Q4	$797M	Sell	6,705,746 -3,743,006	-36%	-$422M	0.75%	43
2014 Q3	$1.17B	Sell	10,448,752 -1,416,257	-12%	-$135M	1.09%	23
2014 Q2	$1.12B	Sell	11,865,009 -739,038	-6%	-$51.8M	1.04%	26
2014 Q1	$891M	Sell	12,604,047 -870,831	-6%	-$69M	0.85%	35
2013 Q4	$1B	Sell	13,474,878 -469,415	-3%	-$32.7M	0.98%	25
2013 Q3	$1.06B	Sell	13,944,293 -3,254,728	-19%	-$259M	1.11%	17
2013 Q2	$1.37B	Buy	+17,199,021	New	+$1.27B	1.55%	8